New Delhi: The central and state drug regulatory bodies have banned the licences of numerous production facilities and revoked the product approvals of a few others, all on the grounds of quality.
The decision by the DGCA was taken after it examined 76 enterprises across 20 states and union territories, with close to 203 firms being identified for review.
DGCI cancels license of 18 pharma companies theindianawaaz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theindianawaaz.com Daily Mail and Mail on Sunday newspapers.